Molecular pathology of endometrial carcinoma: transcriptional signature in endometrioid tumors.
about
Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targetsMicroRNA signature and regulatory functions in the endometrium during normal and disease statesRapamycin inhibits cell proliferation in type I and type II endometrial carcinomas: a search for biomarkers of sensitivity to treatment.Hormone Therapy plus mTOR Inhibitors in the Treatment of Endometrial Carcinoma.Novel synthetic monoketone transmute radiation-triggered NFκB-dependent TNFα cross-signaling feedback maintained NFκB and favors neuroblastoma regression.Radiation-triggered tumor necrosis factor (TNF) alpha-NFkappaB cross-signaling favors survival advantage in human neuroblastoma cellsAssociation of the apolipoprotein E 2 allele with concurrent occurrence of endometrial hyperplasia and endometrial carcinoma.Combination of imatinib mesylate with lithium chloride and medroxyprogesterone acetate is highly active in Ishikawa endometrial carcinoma in vitro.Small non-coding RNA deregulation in endometrial carcinogenesis.Uterine microRNA signature and consequence of their dysregulation in uterine disorders.Deregulation of RAD21 and RUNX1 expression in endometrial cancer.Involvements of Estrogen Receptor, Proliferating Cell Nuclear Antigen and p53 in Endometrial Adenocarcinoma Development in Donryu Rats.Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes.Over-Expression of the LH Receptor Increases Distant Metastases in an Endometrial Cancer Mouse Model.Loss of Mismatch Repair Protein Expression in Unselected Endometrial Adenocarcinoma Precursor Lesions.
P2860
Q26829873-5809D81E-E558-4D22-A0DE-6A50F7286F51Q28475999-229B9857-914D-44FB-98B1-0BCF212BEAF1Q33903478-55DED80C-612E-45E9-AE69-EF809A317D4FQ34571141-E3EDBF02-D858-411D-9462-918E8D2B1703Q34965143-58FFB608-6522-4B15-8405-7D1765597865Q35065235-201C1B3A-FD35-41A7-A639-810D23DF26B3Q35109507-9DBEDFA3-2430-4AE2-8F39-1C0ECA46740AQ35663624-12DDB5B8-5F65-460F-A408-C885898FB77EQ35741534-A9FEEF67-C9F7-4FFE-AC7A-76158C0DAA69Q35746187-CB208CEF-C3DB-4348-A5D5-96F556220125Q36423904-253D7AB0-7F05-4D46-B9AD-0B67E3BE218EQ36455125-F81FFCB9-D9AE-4140-BAC7-B8574BC24D3CQ36477469-7D709105-AA36-4622-96FF-0401A30F574CQ37321844-EF5597DB-3E75-4CFC-B07F-5E92493B5349Q38710498-11633975-D00C-4A33-B7B4-A31BB7D94A4C
P2860
Molecular pathology of endometrial carcinoma: transcriptional signature in endometrioid tumors.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Molecular pathology of endomet ...... nature in endometrioid tumors.
@ast
Molecular pathology of endomet ...... nature in endometrioid tumors.
@en
type
label
Molecular pathology of endomet ...... nature in endometrioid tumors.
@ast
Molecular pathology of endomet ...... nature in endometrioid tumors.
@en
prefLabel
Molecular pathology of endomet ...... nature in endometrioid tumors.
@ast
Molecular pathology of endomet ...... nature in endometrioid tumors.
@en
P2093
P356
P1476
Molecular pathology of endomet ...... nature in endometrioid tumors.
@en
P2093
A Gil-Moreno
J Castellvi
J Planaguma
J Reventos
J Xercavins
M Gonzalez
P304
P356
10.14670/HH-21.197
P577
2006-02-01T00:00:00Z